New experimental AI platform matches tumor to best drug combo — ScienceDaily

Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA). “That’s because right now we can’t match the right combination of drugs to the right patients in a smart way,” said Trey Ideker, PhD, professor at University of California San Diego School of Medicine […]